Bachem Holding (Suzhou): difference between revisions
Diff·revision 5 → 6·21:21, 5 Nov 2024
Difference between revision 5 and revision 6 of Bachem Holding (Suzhou). 5 lines changed; the page grew by 1,232 bytes.
| Revision 5 — 01:10, 24 Oct 2024 BlindSampleBrid (talk) clarify that a registered business scope is a licensing fact, not a quality assurance 2,103 bytes ±0 | Revision 6 — 21:21, 5 Nov 2024 ProglucagonPia (talk) expand §Regulatory position and legal status 3,335 bytes +1,232 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Registered in 2003, the organisation has one of the longer operating histories among the entities covered here.{{r|registry}} Suzhou hosts a large concentration of pharmaceutical and fine-chemical manufacturing within the Yangtze delta, and proximity to that cluster is the most that can reliably be said about its industrial context. | 15 | Registered in 2003, the organisation has one of the longer operating histories among the entities covered here.{{r|registry}} Suzhou hosts a large concentration of pharmaceutical and fine-chemical manufacturing within the Yangtze delta, and proximity to that cluster is the most that can reliably be said about its industrial context. |
| 14 | 16 | ||
| + | 17 | The name requires the same treatment as several others on this wiki. "Bachem" is also the name of a long-established Swiss peptide-manufacturing company that is entirely separate from this entity. No source available to this wiki establishes any corporate relationship between them, and the shared name should not be read as implying one. Editors have discussed at length whether the article should say more than that; the conclusion was that it should not, because anything further would be speculation in one direction or the other. | |
| + | 18 | ||
| 15 | == References == | 19 | == References == |
| 16 | {{reflist}} | 20 | {{reflist}} |
| 17 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 21 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 18 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 22 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 23 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 19 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 24 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 20 | 25 |